CYP2C9*2 AND Phenytoin response
- Germline classification:
- drug response (1 submission)
- Last evaluated:
- Sep 24, 2020
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV001263463.2
Allele description
CYP2C9*2
Condition(s)
- Name:
- Phenytoin response
- Synonyms:
- Dilantin response
- Identifiers:
- MedGen: CN069167
Assertion and evidence details
Last Updated: Aug 26, 2023